CannaMore Biotechs

CannaMore Biotechs is a leading biotechnology research company dedicated to innovation and advancement in the pharmaceutical field. CannaMore Biotechs operates as a robust R&D platform, focusing on multiple pharmaceutical cannabis indications. With a strong foundation and strategic partnerships, CannaMore is uniquely positioned to drive innovation and develop a wide range of cannabis-based drugs. Located at 14 Baruch Hirsh St, Bnei Brak, Israel 5120206, IL, CannaMore Biotechs is committed to pushing the boundaries of biotechnology and delivering cutting-edge solutions.

CannaMore Biotechs benefits from strong collaborations that enhance its capacity to explore and develop novel therapies. The company's focus on pharmaceutical cannabis positions it at the forefront of a rapidly evolving industry, addressing critical medical needs with innovative approaches. CannaMore Biotechs aims to improve patient outcomes and contribute significantly to the advancement of medical science through dedicated research and development efforts.

Through its strategic vision and commitment to excellence, CannaMore Biotechs continues to expand its capabilities and impact in the biotechnology sector. The company is dedicated to maintaining the highest standards of quality and innovation in all its endeavors. We invite the manager of CannaMore Biotechs to create a customized and exclusive company showcase and product listing on our platform to further highlight your achievements and connect with a broader audience.